Abstract

This IDC Survey analyzes how life sciences organizations in Europe are supporting their core business priorities by transforming engagement with patients and customers. It also presents the challenges these organizations must overcome to benefit from technology investments.

The analysis is based on the life sciences sample of IDC's European Healthcare and Life Sciences Insights Survey, 2022. The study explores the strategic business priorities and key action plans of European pharmaceutical companies, medical device manufacturers, and clinical research organizations and the technology investments they are prioritizing to transform end-user engagement and experience.

Coverage